Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Serum adiponectin levels and hepatic diseases.

Zhou D, Lin Z, Kong L, Li J.

Hepatol Res. 2013 Nov;43(11):1253. doi: 10.1111/hepr.12114. No abstract available.

PMID:
23607260
2.

Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.

Korah TE, El-Sayed S, Elshafie MK, Hammoda GE, Safan MA.

World J Hepatol. 2013 Feb 27;5(2):74-81. doi: 10.4254/wjh.v5.i2.74.

3.

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.

Tietge UJ, Böker KH, Manns MP, Bahr MJ.

Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E82-9. Epub 2004 Mar 9.

4.

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.

Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Wada K, Saito S, Terauchi Y, Nakajima A.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21.

PMID:
17331160
5.

[The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].

Li HS, Feng Q, Hu YY, Chen SD, Peng JH, Li XM, Xu LL.

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):826-30. Chinese.

PMID:
19958641
6.

Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.

Zhang X, Li ZZ, Liu DF, Xu X, Mei ZC, Shen W.

Clin Exp Pharmacol Physiol. 2009 Jul;36(7):631-6. doi: 10.1111/j.1440-1681.2008.05129.x. Epub 2008 Nov 28.

PMID:
19076162
7.

Adiponectin and its receptors in patients with chronic hepatitis C.

Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, Powell EE, Tilg H.

J Hepatol. 2005 Dec;43(6):929-36. Epub 2005 Jul 1.

PMID:
16139921
8.

Significance of serum adiponectin levels in patients with chronic liver disease.

Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF.

Clin Sci (Lond). 2010 Aug 5;119(10):431-6. doi: 10.1042/CS20100008.

9.

Serum vascular endothelial growth factor and adiponectin levels in patients with benign and malignant gynecological diseases.

Lasalandra C, Coviello M, Falco G, Divella R, Trojano G, Laterza AM, Quero C, Pepe V, Zito FA, Quaranta M.

Int J Gynecol Cancer. 2010 May;20(4):507-12. doi: 10.1111/IGC.0b013e3181c54fc5.

PMID:
20442584
10.

Serum adiponectin levels and enzyme markers of liver dysfunction in diabetic and non-diabetic Caribbean subjects.

Ezenwaka CE, Kalloo R, Uhlig M, Schwenk R, Eckel J.

Br J Biomed Sci. 2006;63(3):117-22.

PMID:
17058711
11.

Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men.

Kobayashi J, Kusunoki M, Murase Y, Kawashiri M, Higashikata T, Miwa K, Katsuda S, Takata M, Asano A, Nohara A, Inazu A, Mabuchi H.

Horm Metab Res. 2005 Aug;37(8):505-9.

PMID:
16138264
12.

Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease.

Aygun C, Senturk O, Hulagu S, Uraz S, Celebi A, Konduk T, Mutlu B, Canturk Z.

Eur J Gastroenterol Hepatol. 2006 Feb;18(2):175-80.

PMID:
16394799
13.

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.

Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.

Aliment Pharmacol Ther. 2006 Nov 1;24(9):1349-57.

14.

Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.

Zhang W, Wu R, Zhang F, Xu Y, Liu B, Yang Y, Zhou H, Wang L, Wan K, Xiao X, Zhang X.

Clin Exp Pharmacol Physiol. 2012 Dec;39(12):1026-33. doi: 10.1111/1440-1681.12020.

PMID:
23127227
15.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
16.

Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.

Arvaniti VA, Thomopoulos KC, Tsamandas A, Makri M, Psyrogiannis A, Vafiadis G, Assimakopoulos SF, Labropoulou-Karatza C.

Acta Gastroenterol Belg. 2008 Oct-Dec;71(4):355-60. Erratum in: Acta Gastroenterol Belg. 2009 Apr-Jun;72(2):280. Asimakopoulos, S [corrected to Assimakopoulos, S F].

PMID:
19317274
17.

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

Moschen AR, Molnar C, Wolf AM, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser PL, Tilg H.

J Hepatol. 2009 Oct;51(4):765-77. doi: 10.1016/j.jhep.2009.06.016. Epub 2009 Jul 5.

PMID:
19664840
18.

The evolving role of leptin and adiponectin in chronic liver diseases.

Tsochatzis E, Papatheodoridis GV, Archimandritis AJ.

Am J Gastroenterol. 2006 Nov;101(11):2629-40. Epub 2006 Sep 4. Review. Erratum in: Am J Gastroenterol. 2006 Dec;101(12):2915.

PMID:
16952281
19.

HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.

Chang ML, Yeh HC, Tsou YK, Wang CJ, Cheng HY, Sung CM, Ho YP, Chen TH, Yeh CT.

Obesity (Silver Spring). 2012 Jul;20(7):1474-80. doi: 10.1038/oby.2012.45. Epub 2012 Feb 23.

20.

Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels.

Qin Y, Tian YP.

Mol Med Rep. 2010 May-Jun;3(3):525-30. doi: 10.3892/mmr_00000292.

PMID:
21472274
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk